These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 17136027)

  • 21. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physiologic compensation is supranormal in compensated aortic stenosis: does it return to normal after aortic valve replacement or is it blunted by coexistent coronary artery disease? An intramyocardial magnetic resonance imaging study.
    Biederman RW; Doyle M; Yamrozik J; Williams RB; Rathi VK; Vido D; Caruppannan K; Osman N; Bress V; Rayarao G; Biederman CM; Mankad S; Magovern JA; Reichek N
    Circulation; 2005 Aug; 112(9 Suppl):I429-36. PubMed ID: 16159858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between serum albumin level before initiating haemodialysis and angiographic severity of coronary atherosclerosis in end-stage renal disease patients.
    Joki N; Hase H; Tanaka Y; Takahashi Y; Saijyo T; Ishikawa H; Inishi Y; Imamura Y; Hara H; Tsunoda T; Nakamura M
    Nephrol Dial Transplant; 2006 Jun; 21(6):1633-9. PubMed ID: 16488920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive markers of asymptomatic atherosclerosis in end-stage renal disease patients.
    Mutluay R; Konca C; Erten Y; Paşaoğlu H; Değer SM; Ağirgün C; Derici U; Arinsoy T; Sindel S
    Ren Fail; 2010 May; 32(4):448-54. PubMed ID: 20446782
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apelin: a potential link between inflammation and cardiovascular disease in end stage renal disease patients.
    El-Shehaby AM; El-Khatib MM; Battah AA; Roshdy AR
    Scand J Clin Lab Invest; 2010 Oct; 70(6):421-7. PubMed ID: 20645679
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease-impact of calcium and vitamin D therapy.
    Briese S; Wiesner S; Will JC; Lembcke A; Opgen-Rhein B; Nissel R; Wernecke KD; Andreae J; Haffner D; Querfeld U
    Nephrol Dial Transplant; 2006 Jul; 21(7):1906-14. PubMed ID: 16554325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac consequences of hypertension in hemodialysis patients.
    Zoccali C; Benedetto FA; Tripepi G; Mallamaci F
    Semin Dial; 2004; 17(4):299-303. PubMed ID: 15250922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for significant coronary artery disease in high-risk renal transplant candidates.
    Gowdak LH; de Paula FJ; César LA; Martinez Filho EE; Ianhez LE; Krieger EM; Ramires JA; de Lima JJ
    Coron Artery Dis; 2007 Nov; 18(7):553-8. PubMed ID: 17925609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nocturnal hemodialysis increases arterial baroreflex sensitivity and compliance and normalizes blood pressure of hypertensive patients with end-stage renal disease.
    Chan CT; Jain V; Picton P; Pierratos A; Floras JS
    Kidney Int; 2005 Jul; 68(1):338-44. PubMed ID: 15954925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence of coronary artery disease before valvular surgery in isolated severe aortic stenosis.
    Cho EJ; Park SJ; Chang SA; Jeong DS; Lee SC; Park SW; Park PW
    Chin Med J (Engl); 2014; 127(22):3963-9. PubMed ID: 25421198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haemodialysis impairs clopidogrel but not aspirin responsiveness in patients with end-stage renal disease. Results of a pilot study.
    Htun P; Kan T; Mueller E; Pohle C; Schindler R; Geisler T; Gawaz M; Bocksch W; Fateh-Moghadam S
    Thromb Haemost; 2014 Apr; 111(4):662-9. PubMed ID: 24337367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential survival after coronary revascularization procedures among patients with renal insufficiency.
    Szczech LA; Reddan DN; Owen WF; Califf R; Racz M; Jones RH; Hannan EL
    Kidney Int; 2001 Jul; 60(1):292-9. PubMed ID: 11422764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of myocardial perfusion imaging in patients with end-stage renal disease undergoing coronary angiography.
    Venkataraman R; Hage FG; Dorfman T; Heo J; Aqel RA; de Mattos AM; Iskandrian AE
    Am J Cardiol; 2008 Dec; 102(11):1451-6. PubMed ID: 19026294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired resistance artery function in patients with end-stage renal disease.
    Luksha N; Luksha L; Carrero JJ; Hammarqvist F; Stenvinkel P; Kublickiene K
    Clin Sci (Lond); 2011 Jun; 120(12):525-36. PubMed ID: 21222655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation and treatment of coronary artery disease in patients with end-stage renal disease.
    McCullough PA
    Kidney Int Suppl; 2005 Jun; (95):S51-8. PubMed ID: 15882314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of aortic distensibility in patients with coronary artery disease by use of cine magnetic resonance.
    Matsumoto Y; Honda T; Hamada M; Matsuoka H; Hiwada K
    Angiology; 1996 Feb; 47(2):149-55. PubMed ID: 8595010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional aortic compliance studied by magnetic resonance imaging: the effects of age, training, and coronary artery disease.
    Mohiaddin RH; Underwood SR; Bogren HG; Firmin DN; Klipstein RH; Rees RS; Longmore DB
    Br Heart J; 1989 Aug; 62(2):90-6. PubMed ID: 2765331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations of arterial function in end-stage renal disease.
    London GM
    Nephron; 2000 Feb; 84(2):111-8. PubMed ID: 10657710
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coronary artery distensibility assessed by 3.0 Tesla coronary magnetic resonance imaging in subjects with and without coronary artery disease.
    Kelle S; Hays AG; Hirsch GA; Gerstenblith G; Miller JM; Steinberg AM; Schär M; Texter JH; Wellnhofer E; Weiss RG; Stuber M
    Am J Cardiol; 2011 Aug; 108(4):491-7. PubMed ID: 21624552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduced gene expression of adiponectin in fat tissue from patients with end-stage renal disease.
    Marchlewska A; Stenvinkel P; Lindholm B; Danielsson A; Pecoits-Filho R; Lönnqvist F; Schalling M; Heimbürger O; Nordfors L
    Kidney Int; 2004 Jul; 66(1):46-50. PubMed ID: 15200411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.